EGFR c.2075T>C ;(p.L692P)

Variant ID: 7-55241627-T-C

NM_005228.3(EGFR):c.2075T>C;(p.L692P)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


[Research Progress in Consistency of Driver Gene Status between Primary and Corresponding Metastatic Lesions in Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Zhou, Bing B; Xiong, Jianping J
Publication Date: 2020-03-20

Variant appearance in text: EGFR: L692P
PubMed Link: 32102137
Variant Present in the following documents:
  • Main text
  • zgfazz-23-3-196.pdf
View BVdb publication page



[A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer
with Uncommon EGFR Mutations].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Du, Wenxing W; Wo, Yang Y; Lu, Tong T; Wang, Yuanyong Y; Jiao, Wenjie W
Publication Date: 2019-09-20

Variant appearance in text: EGFR: L692P
PubMed Link: 31526464
Variant Present in the following documents:
  • Main text
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: EGFR: L692P
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 1
View BVdb publication page



Efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in targeted therapy of lung squamous cell carcinoma patients with EGFR mutation: a pooled analysis.

Oncotarget
Zhuang, Jingqi J; Yu, Yongfeng Y; Li, Ziming Z; Lu, Shun S
Publication Date: 2017-08-08

Variant appearance in text: EGFR: L692P
PubMed Link: 28881841
Variant Present in the following documents:
  • Main text
  • oncotarget-08-53675.pdf
View BVdb publication page



Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

British Journal Of Cancer
Kalikaki, A A; Koutsopoulos, A A; Trypaki, M M; Souglakos, J J; Stathopoulos, E E; Georgoulias, V V; Mavroudis, D D; Voutsina, A A
Publication Date: 2008-09-16

Variant appearance in text: EGFR: L692P
PubMed Link: 19238633
Variant Present in the following documents:
  • Main text
  • 6604629a.pdf
View BVdb publication page



'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer.

British Journal Of Cancer
Pallis, A G AG; Voutsina, A A; Kalikaki, Ar A; Souglakos, J J; Briasoulis, E E; Murray, S S; Koutsopoulos, A A; Tripaki, M M; Stathopoulos, E E; Mavroudis, D D; Georgoulias, V V
Publication Date: 2007-12-03

Variant appearance in text: EGFR: L692P
PubMed Link: 18000506
Variant Present in the following documents:
  • Main text
View BVdb publication page